This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
SAN FRANCISCO — Qiagen plans to be aggressive in the mergers and acquisitions market this year and the firm believes the rapid emergence of molecular diagnostics will drive greater sales growth, CEO Peer Schatz told BioCommerce Week in an interview last week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.